Abiopharma

🔍 Tether Global Investments Fund, S.I.C.A.F., S.A. (Executive)

Company: Gold.com, Inc. (GOLD)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 530,338 shares of Common Stock at $44.5 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: false | shares_owned_after: 3,370,787.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4

Footnotes:

• F1: On February 4, 2026, TPM, S.A. de C.V. ("TPM"), a controlled subsidiary of Tether Global Investments Fund, S.I.C.A.F., S.A. (f/k/a Tether Holdings, S.A. de C.V.) ("Tether"), entered into a Securities Purchase Agreement with the Issuer, as amended by Amendment No. 1, dated February 5, 2026 (as so amended, the "Purchase Agreement"). Pursuant to the Purchase Agreement, TPM agreed to purchase an aggregate of 3,370,787 shares of the Issuer's common stock at a price of $44.50 per share, to be settled in two tranches as part of a $150 million private placement of equity securities (the "PIPE Financing").
• F2: Represents the second tranche under the Purchase Agreement, consisting of 530,338 shares of the Issuer's common stock acquired for an aggregate purchase price of $23.6 million.
• F3: Represents an aggregate of 3,370,787 shares of the Issuer's common stock acquired by TPM, comprising the first tranche of 2,840,449 shares acquired for an aggregate purchase price of $126.4 million and the second tranche of 530,338 shares acquired for an aggregate purchase price of $23.6 million.
• F4: Represents securities directly held by TPM, a controlled subsidiary of Tether. Mr. Devasini has a greater than 50% voting interest in Tether. Each of Tether and Mr. Devasini disclaims beneficial ownership of the securities owned by TPM in excess of their respective pecuniary interest therein.